Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethyl Chloride for Pain in NPWT Dressing Changes
NCT04635696Phase 4
Key facts
- Status
- Completed
- Start
- Jan 2019
- Primary completion
- Dec 2020
- Countries
- 1
- Sponsor
- Promedica International
- Modality
- Small Molecules
- Drugs
- ethyl chloride
- Conditions
- procedural pain
01
Overview
Phase 4, randomised, single-blind trial in procedural pain comparing Ethyl Chloride with Placebo (2 arms). Primary endpoints: Patient-reported post procedure pain and Patient-reported during procedure pain. Started Jan 2019; status: completed.
02
Design
2 arms- Study design
- RandomizedSingle-blind
Ethyl Chloride
Ethyl Chloride topical anesthetic mist sprayed on adhesive during dressing change.
Placebo
Tissue culture grade water mist sprayed on adhesive during dressing change.
03
Endpoints
Primary
Patient-reported post procedure pain
Patient-reported during procedure pain
Secondary
Change in pain score from pre-procedure to post-procedure
Change in pain score from pre-procedure to during procedure
Beyond the preview
Go deeper on NCT04635696.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04635696.